Overcoming therapy resistance also involves TRAIL resistance of glioma tumor cells, and progress has been made even in this regard by sensitizing tumor cells to TRAIL-induced apoptosis through inhibition of KDM2B and eIF5B. This evidence concerns the gene KDM2B and glioma.